Regulatable promoters for use in gene therapy applications: Modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP

Human Gene Therapy

Volumn 7, Issue 15, 1996, Pages 1883-1893

  Suzuki, Motoyoshi ^a   Singh, Ravi N ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DNA FRAGMENT; FORSKOLIN; LUCIFERASE; PHOSPHODIESTERASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENOVIRUS; ARTICLE; CHIMERA; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PLASMID; PROMOTER REGION; REPORTER GENE; RESPIRATORY EPITHELIUM; TANDEM REPEAT;

ADENOVIRIDAE; ESCHERICHIA COLI; RICE STRIPE VIRUS;

EID: 0029858012     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.15-1883     Document Type: Article

References (44)

1. ALTON, E.W.F.W., MIDDLETON, P.G., CAPLEN, N.J., SMITH, S.N., STEEL, D.M., MUNKONGE, F.M., JEFFERY, P.K., GEDDES, D.M., HART, S.L., WILLIAMSON, R. FASOLD, K.I., MILLER, A.D., DICKINSON, P., STEVENSON, B.J., McLACHLAN, G., DORIN, J.R., and PORTEOUS, D.J. (1993). Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5, 135-142.
2. BETT, A.J., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
3. BOUCHER, R.C., KNOWLES, M.R., JOHNSON, L.G., OLSEN, J.C., PICKLES, R., WILSON, J.M., ENGELHARDT, J., YANG, Y., and GROSSMAN, M. (1994). Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5, 615-639.
4. CAPLEN, N.J., ALTON, E.W.F.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S.R., JEFFERY, P.K., HUDSON, M.E., COUTELLE, C., HUANG, L., PORTEOUS, D.J., WILLIAMSON, R., and GEDDES, D.M. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46.
5. CHENG, L., ZIEGELHOFFER, P.R., and YANG, N.S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455-4459.
6. CHOU, J., ROZMAHEL, R., and TSUI, L. (1991). Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. J. Biol. Chem. 266, 24471-24476.
7. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
8. CRYSTAL, R.G., McELVANEY, N.G., ROSENFELD, M.A., CHU, C., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42-51.
9. CRYSTAL, R.G., JAFFE, A., BRODY, S., MASTRANGELI, A., McELVANEY, N.G., ROSENFELD, M., CHU, C., DANEL, C., HAY, J., and EISSA, T. (1995). A phase I study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum. Gene Ther. 6, 643-666.
10. DE WET, J.R., WOOD, K.V., DE LUCA, M., HELINSKI, D.R., and SUBRAMANI, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737.
11. FURTH, P.A., ST ONGE, L., BOGER, H., GRUSS, P., GOSSEN, M., KISTNER, A., BUJARD, H., and HENNIGHAUSEN, L. (1994). Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302-9306.
12. GAZIT, G., KANE, S.E., NICHOLS, P., and LEE, A.S. (1995). Use of the stress-inducible grp78/bip promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res. 55, 1660-1663.
13. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
14. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.
15. HAY, J.G., McELVANEY, N.G., HERENA, J., and CRYSTAL, R.G. (1995). Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6, 1487-1496.
16. HAYASHI, Y., DE PAOLI, A.M., BURANT, C.F., and REFETOFF, S. (1994). Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J. Biol. Chem. 269, 23872-23875.
17. HAZINSKI, T.A., LADD, P.A., and DE MATTEO, C.A. (1991). Localization and induced expression of fusion genes in the rat lung. Am. J. Respir. Cell. Mol. Biol. 4, 206-209.
18. JONES, S.N., JONES, P.G., IBARGUEN, H., CASKEY, C.T., and CRAIGEN, W.J. (1991). Induction of the cypIa-1 dioxin-responsive enhancer in transgenic mice. Nucleic Acids Res. 19, 6547-6551.
19. KOH, J., SFERRA, T.J., and COLLINS, F.S. (1993). Characterization of the cystic fibrosis transmembrane conductance regulator promoter region; Chromatin context and tissue-specificity. J. Biol. Chem. 268, 15912-15921.
20. KOTHARY, R., CLAPOFF, S., DARLING, S., PERRY, M.D., MORAN, L.A., and ROSSANT, J. (1989). Inducible expression of an hsp68-lacz hybrid gene in transgenic mice. Development 105, 707-714.
21. LA GAMMA, E.F., STRECKER, R.E., LENN, N.J., DE CRISTOFARO, J.D., and WEISINGER, G. (1994). Dopaminergic regulation of a transfected preproenkephalin promoter in primary rat astrocytes in vitro and in vivo. Exp. Neurol. 130, 304-310.
22. LIU, J.M., FUJII, H., GREEN, S.W., KOMATSU, N., YOUNG, N.S., and SHIMADA, T. (1991). Indiscriminate activity from the B19 parvovirus P6 promoter in nonpermissive cells. Virology 182, 361-364.
23. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91, 225-234.
24. McGRANE, M.M., YUN, J.S., PATEL, Y.M., and HANSON, R.W. (1992). Metabolic control of gene expression: in vivo studies with transgenic mice. Trends Biochem. Sci. 17, 40-44.
25. McGRORY, W.J., BAUTISTA, D.S., and GRAHAM, F.L. (1988). A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617.
26. MEYER, R.B., JR., and MILLER, J.P. (1974). Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci. 14, 1019-1040.
27. MULLER, M., BRENIG, B., WINNACKER, E.L., and BREM, G. (1992). Transgenic pigs carrying cDNA copies encoding the murine Mx1 protein which confers resistance to influenza virus infection. Gene 121, 263-270.
28. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE. (1991). Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J. Allergy Clin. Immunol. 88, 425-534.
29. NEUMANN, J.R., MORENCY, C.A., and RUSSIAN, K.O. (1987). A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5, 444-447.
30. PALMITER, R.D., CHEN, H.Y., and BRINSTER, R.L. (1982). Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell 29, 701-710.
31. ROESLER, W.J., VANDENBARK, G.R., and HANSON, R.W. (1988). Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263, 9063-9066.
32. SCHOENBERGER, O.L., BEIKIRCH, S., TREFZ, G., DRINGS, P., and EBERT, W. (1987). Proteolytic activity of human tumor cell lines deriving from bronchial squamous cell carcinoma, pulmonary metastasis of rhabdomyosarcoma and pleural metastasis of mesothelioma. Eur. J. Respir. Dis. 71, 434-443.
33. SHORT, J.M., WYNSHAW-BORIS, A., SHORT, H.P., and HANSON, R.W. (1986). Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. J. Biol. Chem. 261, 9721-9726.
34. STAMMINGER, T., FICKENSCHER, H., and FLECKENSTEIN, B. (1990). Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J. Gen. Virol. 71, 105-113.
35. TEPPER, R.I., LEVINSON, D.A., STANGER, B.Z., CAMPOS-TORRES, J., ABBAS, A.K., and LEDER, P. (1990). IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62, 457-467.
36. TRAPNELL, B.C., CHU, C., PAAKKO, P.K., BANKS, T.C., YOSHIMURA, K., FERRANS, V.J., CHERNICK, M.S., and CRYSTAL, R.G. (1991). Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. USA 88, 6565-6569.
37. VARLEY, A.W., COULTHARD, M.G., MEIDELL, R.S., GERARD, R.D., and MUNFORD, R.S. (1995). Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. USA 92, 5346-5350.
38. WELSH, M.J., SMITH, A.E., ZABNER, J., RICH, D.P., GRAHAM, S.M., GREGORY, R.J., PRATT, B.M., and MOSCICKI, R.A. (1994). Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5, 209-219.
39. WIDDICOMBE, J.H. (1986). Cystic fibrosis and beta-adrenergic response of airway epithelial cell cultures. Am. J. Physiol. 251, R818-R822.
40. WILMOTT, R.W., WHITSETT, J., and TRAPNELL, B. (1993). A phase I study of gene therapy of cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. Fed. Register 58, 21739.
41. WILSON, J.M., ENGELHARDT, J.F., GROSSMAN, M., SIMON, R.H., and YANG, Y. (1994). Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: A phase I trial. Hum. Gene Ther. 5, 501-519.
42. YOSHIMURA, K., NAKAMURA, H., TRAPNELL, B.C., DALEMANS, W., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1991). The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J. Biol. Chem. 266, 9140-9144.
43. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
44. ZEITLIN, P.L., LU, L., RHIM, J., CUTTING, G., STETTEN, G., KIEFFER, K.A., CRAIG, R., and GUGGINO, W.B. (1991). A cystic fibrosis bronchial epithelial cell line: immortalization by adeno12-SV-40 infection. Am. J. Respir. Cell. Mol. Biol. 4, 313-319.